Pharmagen, Inc. announced that on June 30, 2014, Richard A. Wolpow resigned as chairman of the board and director; Danny M. Barnes, David S. Rowley and Stephen M. Perry resigned as directors; Boyd P. Relac resigned as chief operating officer and secretary; and Russell Skibsted resigned as executive vice president, chief financial officer and principal financial officer.